Table 2.
Different groups of differently expressed genes involved in KEGG.
| Healthy vs. acutely infected, dead pigs | ||||||||
|---|---|---|---|---|---|---|---|---|
| B cell receptor signaling pathway | log2 (Fold Change) | Endocytosis | log2 (Fold Change) | Transcriptional misregulation in cancer | log2 (Fold Change) | Protein processing in endoplasmic reticulum | log2 (Fold Change) | |
| Significantly upregulated genes | ||||||||
| BLNK | 5.94 | HSH2D | 11.11 | MMP3 | 9.48 | UBE2J1 | 4.59 | |
| CD79A | 5.66 | AMPH | 7.36 | TLX1 | 8.54 | BAG2 | 3.68 | |
| RASGEF1A | 5.03 | SH3GL3 | 5.06 | A179L | 6.97 | HSPA14 | 3.56 | |
| RASGRP3 | 4.05 | STARD7 | 4.85 | WT1 | 5.08 | AMBN | 3.55 | |
| BTK | 3.97 | SH3KBP1 | 4.627 | IL6 | 5.07 | XAF1 | 3.49 | |
| RAC2 | 3.87 | DEPDC1B | 3.99 | ARNT2 | 4.72 | TICRR | 3.41 | |
| STAC2 | 3.80 | SNX32 | 3.93 | AZU1 | 4.17 | EIF2S1 | 3.06 | |
| SASH3 | 3.59 | ARPC5L | 3.85 | CCND2 | 3.69 | HSPA2 | 2.98 | |
| NRAS | 3.33 | STAC2 | 3.80 | BCL2A1 | 3.39 | BAK1 | 2.94 | |
| CARD11 | 3.27 | POF1B | 3.66 | TAF15 | 3.27 | ANKRD33B | 2.59 | |
| Significantly downregulated genes | ||||||||
| MAB21L3 | -4.97 | TFR2 | -10.26 | IGFBP1 | -11.67 | C9H1orf116 | -8.03 | |
| JUN | -4.86 | AZGP1 | -9.72 | IGFBP2 | -10.98 | ESPN | -5.62 | |
| RAC3 | -4.15 | ROGDI | -9.61 | TMPRSS2 | -6.90 | RRBP1 | -5.16 | |
| FOS | -4.07 | FGFRL1 | -8.85 | C15H2orf72 | -6.61 | SVIP | -5.01 | |
| YPEL2 | -2.41 | FGFR3 | -8.77 | IGF1 | -5.74 | MAN1C1 | -4.99 | |
| PYGO1 | -6.19 | CD14 | -5.69 | PRADC1 | -4.39 | |||
| FXYD7 | -5.98 | SPINT1 | -5.65 | TMEM161A | -4.15 | |||
| ESPN | -5.62 | GADD45G | -5.64 | GKAP1 | -4.14 | |||
| FOLR2 | -5.41 | GOLIM4 | -5.54 | C2H19orf24 | -3.96 | |||
| LMF1 | -4.91 | TSPAN7 | -5.48 | CANX | -3.83 | |||
| Healthy vs. cohabiting asymptomatic pigs | ||||||||
| B cell receptor signaling pathway | log2 (Fold Change) | Endocytosis | log2 (Fold Change) | Transcriptional misregulation in cancer | log2 (Fold Change) | Protein processing in endoplasmic reticulum | log2 (Fold Change) | |
| Significantly upregulated genes | ||||||||
| CD79A | 9.67 | HSH2D | 8.06 | TLX1 | 9.12 | BAG2 | 4.05 | |
| CD19 | 6.45 | AMPH | 7.11 | FRMPD1 | 7.75 | CNFN | 3.66 | |
| CR1 | 6.31 | GSG1L | 6.00 | PPARG | 7.68 | UBE2J1 | 3.65 | |
| CD22 | 5.61 | CXCR2 | 5.04 | GSG1L | 6.00 | HSPA2 | 3.32 | |
| BLNK | 5.41 | STARD7 | 4.92 | MMP3 | 5.72 | ARID5A | 3.04 | |
| SASH3 | 4.84 | MAATS1 | 4.71 | WT1 | 5.70 | HSPA14 | 3.01 | |
| CD79B | 4.78 | CXCR4 | 4.59 | PAX5 | 5.26 | TICRR | 2.98 | |
| BTK | 4.62 | SNX32 | 4.51 | ARNT2 | 5.22 | EIF2S1 | 2.73 | |
| GRAP | 4.49 | STAC3 | 4.49 | LMO1 | 4.34 | ERO1A | 2.73 | |
| INPP5D | 4.45 | SH3GL3 | 4.45 | CD40 | 3.97 | BAX | 2.71 | |
| Significantly downregulated genes | ||||||||
| FOS | -4.44 | AZGP1 | -12.23 | IGFBP1 | -12.09 | C9H1orf116 | -8.16 | |
| JUN | -4.10 | TFR2 | -8.60 | IGFBP2 | -10.12 | ANKRD33 | -6.37 | |
| MAB21L3 | -3.28 | FGFRL1 | -8.21 | TMPRSS2 | -7.93 | LMAN1 | -5.46 | |
| KRAS | -2.63 | FGFR3 | -7.61 | NUPR1 | -6.56 | RRBP1 | -5.45 | |
| CMTM8 | -5.56 | MET | -5.95 | SVIP | -5.31 | |||
| ESPN | -4.80 | GOLIM4 | -5.90 | C2H19orf24 | -5.10 | |||
| WASL | -4.73 | ANKDD1B | -5.75 | ESPN | -4.79 | |||
| PYGO1 | -4.71 | IGF1 | -5.74 | PRADC1 | -4.54 | |||
| ROGDI | -4.60 | GADD45G | -5.00 | SEC62 | -4.25 | |||
| LMF1 | -4.58 | CD14 | -4.55 | MAN1C1 | -4.12 | |||
| Cohabiting asymptomatic vs. acutely infected, dead pigs | ||||||||
| B cell receptor signaling pathway | log2 (Fold Change) | Endocytosis | log2 (Fold Change) | Transcriptional misregulation in cancer | log2 (Fold Change) | Protein processing in endoplasmic reticulum | log2 (Fold Change) | |
| Significantly upregulated genes | ||||||||
| XAF1 | 4.07 | A179L | 6.58 | XAF1 | 4.07 | |||
| HSH2D | 3.56 | FCGR1A | 5.27 | TXNDC5 | 2.34 | |||
| POF1B | 3.02 | NUPR1 | 4.72 | MFSD2B | 2.24 | |||
| CAV2 | 2.43 | MMP3 | 4.42 | LMAN1 | 2.19 | |||
| CAV1 | 2.17 | IFI6 | 4.36 | ERN1 | 2.03 | |||
| FAM174B | 2.12 | ISG12(A) | 4.22 | SEC24A | 2.02 | |||
| GZMB | 3.38 | SEC24D | 2.01 | |||||
| IL6 | 2.60 | |||||||
| CXCL8 | 2.39 | |||||||
| AZU1 | 2.37 | |||||||
| Significantly downregulated genes | ||||||||
| CR1 | -4.97 | GSG1L | -4.60 | FRMPD1 | -6.29 | OS9 | -2.89 | |
| CD79A | -4.06 | CXCR2 | -4.45 | CSF1R | -5.38 | CENPV | -2.87 | |
| CD19 | -3.77 | FOLR1 | -3.70 | PPARG | -5.19 | CNFN | -2.41 | |
| CD22 | -3.13 | HFE | -3.42 | GSG1L | -4.60 | PHLDB3 | -2.11 | |
| CD72 | -3.10 | DNM1 | -2.78 | SLC45A3 | -4.10 | |||
| CD79B | -2.72 | CCER2 | -2.75 | ETV5 | -3.93 | |||
| RAC3 | -2.14 | FXYD7 | -2.52 | PAX5 | -3.39 | |||
| YPEL2 | -2.13 | TNFAIP8L2 | -2.49 | CEBPA | -3.1 | |||
| PRKCZ | -2.28 | SPINT1 | -3.10 | |||||
| GRK3 | -2.24 | TRABD2A | -2.92 | |||||